149,936 members

Skip to content. | Skip to navigation

News

Green light for peripheral arterial disease drug

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

Green light for peripheral arterial disease drug

NICE has approved the use of the vasodilator drug naftidrofuryl oxalate for people with peripheral arterial disease (PAD).

PAD is a condition in which there is a blockage or narrowing of the arteries that carry blood to the legs and arms caused mainly by fatty deposits on the arterial walls. Final guidance was published this week.